We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Aquablation therapy for symptomatic benign prostatic hyperplasia: a single-centre experience in 47 patients.
- Authors
Desai, Mihir M.; Singh, Abhishek; Abhishek, Shashank; Laddha, Abhishek; Pandya, Harshad; Ashrafi, Akbar N.; Ganpule, Arvind P.; Roehrborn, Claus G.; Thomas, Andrew J.; Desai, Mahesh; Sabnis, Ravindra B.
- Abstract
Objective: To report procedure process improvements and confirm the preserved safety and short-term effectiveness of a secondgeneration Aquablation device for the treatment of lower urinary tract symptoms (LUTS) attributable to benign prostatic hyperplasia (BPH) in 47 consecutive patients at a single institution. Patients and Methods: Aquablation was performed in 47 patients with symptomatic BPH at a single institution. Baseline, peri-operative and 3-month urinary function data were collected. Results: The mean (range) patient age was 66 (50-79) years, and transrectal ultrasonography-measured prostate volume was 48 (20-118) mL. A median lobe was present in 25 patients (53%) and eight patients had catheter-dependent urinary retention. The mean (range) total procedure time was 35 (13-128) min and the tissue resection time was 4 (1-10) min. Five Clavien-Dindo grade I/II and five Clavien-Dindo grade III complications were recorded in eight patients. The mean (range) hospital stay was 3.1 (1-8) days and the mean (range) duration of urethral catheterization was 1.9 (1-11) days. The mean International Prostate Symptom Score (IPSS) decreased from 24.4 at baseline to 5 at 3 months; IPSS quality-of-life score decreased from 4.5 to 0.3 points; peak urinary flow rate increased from 7.1 to 16.5 mL/s and post-void residual urine volume decreased from 119 to 43 mL (all P < 0.01). Conclusions: This study confirmed procedure process improvements resulting from system enhancements, with preservation of safety and effectiveness during use of a second-generation device for the treatment of LUTS attibutable to BPH in the largest single-institution study conducted to date.
- Subjects
ROBOTICS; QUALITY of life; ULTRASONIC imaging; URINARY catheterization; BENIGN prostatic hyperplasia
- Publication
BJU International, 2018, Vol 121, Issue 6, p945
- ISSN
1464-4096
- Publication type
Article
- DOI
10.1111/bju.14126